Bracelet type snorting drug delivery device

Abstract

The utility model relates to the field of medical instruments, in particular to a bracelet type snorting drug delivery device which comprises an annular belt, a drug cabin, a drug delivery hole, an opening and closing mechanism and a drug inlet. The two ends of the medicine cabin are movably connected with the two ends of the annular belt respectively, the medicine cabin is communicated with the atmosphere through the medicine feeding hole, and the opening and closing mechanism is connected with the medicine cabin in a sleeved mode and movably connected with the medicine feeding hole. The medicine cabin comprises a medicine storage cabin and two end cabins, the two end cabins are detachably connected with the two ends of the medicine storage cabin respectively, and the medicine inlet is formed in the middle of the medicine cabin and used for injecting medicine; when the medicine is liquid medicine, an atomization system, a timing system and a flow monitoring system are additionally arranged, the atomization system, the timing system and the flow monitoring system are integrated into the end cabin, the flow monitoring system is electrically connected with the atomization system, and a flow velocity sensor can monitor the medicine atomization flow in real time and feed the medicine atomization flow back to the atomization system. The accuracy of the dosage is further guaranteed, and the treatment process is more scientific and reliable.

Description

Technical Field

[0001] This utility model relates to a medical device, specifically a wristband-type nasal inhalation drug delivery device. Background Technology

[0002] Nasal sprays or nasal drops are commonly used forms of medication for treating nasal diseases such as allergic rhinitis and sinusitis, but they often have many problems such as uneven dosage, inaccurate application site, and difficulty in spraying.

[0003] In terms of operation, many current devices may be too large and complex for children. Children's small hands may find it difficult to grasp and operate the device correctly, and the shape and size of the nozzle may not be suitable for their nasal structure, easily causing fear and resistance, affecting the accurate spraying of medication. Furthermore, as people age, their vision, hand dexterity, and coordination may decline. Some devices have complex nozzle designs that require a certain amount of strength and skill to operate, which may be difficult for the elderly. Regarding the structural defects of the spray bottle, an enlarged nozzle at the interface may repeatedly hit the nasal cavity wall, damaging the nasal mucosa and causing bleeding. In addition, the size and shape of these devices may be too large for children to operate independently, significantly increasing the burden on parents. Regarding the administration location and dosage, improper spraying or inhalation due to difficulty in controlling the dosage can easily cause some medication to flow out of the nasal cavity or into the throat, reducing its effectiveness.

[0004] Furthermore, since nasal diseases often require repeated administration of small doses, many patients tend to take medication irregularly and only when their condition flares up, thus delaying treatment.

[0005] Therefore, there is an urgent need for a simple-to-operate drug delivery device that can deliver drugs quantitatively, precisely, and at specific times. Utility Model Content

[0006] The purpose of this invention is to provide a wristband-type nasal inhalation drug delivery device to solve the problems mentioned in the background art.

[0007] To achieve the above objectives, this utility model provides the following technical solution: a wristband-type nasal inhalation drug delivery device, comprising a wristband, a drug chamber, a drug delivery port, an opening and closing mechanism, and a drug inlet;

[0008] The two ends of the medicine chamber are movably connected to the two ends of the ring belt, the drug administration port is set on the upper surface of the medicine chamber, and the medicine chamber is connected to the atmosphere through the drug administration port. The opening and closing mechanism is sleeved with the medicine chamber, and the lower surface of the opening and closing mechanism is movably connected to the drug administration port.

[0009] The medicine compartment includes a medicine storage compartment and two end compartments, and the two end compartments are detachably connected to the two ends of the medicine storage compartment, respectively.

[0010] The inlet is located in the middle of the medicine compartment. The inlet includes an inlet hole and a cover, and the cover and the inlet hole are hinged.

[0011] The opening and closing mechanism includes a rotating ring and a cover plate;

[0012] The cover plate is fixedly connected to the rotating ring, and the lower surface of the cover plate is in close contact with the drug delivery port;

[0013] The rotating ring is located at the connection between the medicine storage compartment and the end compartment, and the rotating ring is sleeved with the medicine compartment.

[0014] The aforementioned wristband-type nasal inhalation drug delivery device further includes an atomization system in the drug compartment. The atomization system is located at the end of the drug storage compartment and the end compartment away from the drug delivery port. The atomization system includes an atomizing plate, a battery, an atomization drive template, and an atomization button.

[0015] The atomization button is located on the lower side of the outer surface of the end chamber. The atomization button is connected to the end chamber, and the other end of the atomization button is connected to the atomization drive module.

[0016] The atomizing drive module is located inside the end compartment and is positioned to the side of the battery. The atomizing drive module is electrically connected to the battery.

[0017] The battery is located inside the end compartment and is electrically connected to the atomizing plate;

[0018] The atomizing plate is fixedly connected to the inner surface of the drug storage chamber at the end away from the drug delivery port.

[0019] The aforementioned wristband-type nasal inhalation drug delivery device also includes a timing system in the drug compartment. The timing system is located inside the end compartment near the nebulization system. The timing system includes a time integration template, a micro vibration motor, and an input button.

[0020] The input button is located to the side of the atomizing button. The input button is electrically connected to the battery and also electrically connected to the time integration module.

[0021] The time-integrated template is located on one side of the atomization drive template and is electrically connected to the micro vibration motor.

[0022] The miniature vibration motor is fixedly connected to the inner surface of the end chamber.

[0023] The above-mentioned wristband-type nasal inhalation drug delivery device includes an input button, a cancel button, and an interval button;

[0024] The interval button sets the interval information based on the number of times it is pressed. Specifically, when the number of presses is n, the interval information is n hours, where n is less than or equal to 12.

[0025] Interval information is temporarily stored in the time integration template;

[0026] The time integration template temporarily stores interval information. You can save the interval information by clicking the confirm button or delete the interval information by clicking the cancel button.

[0027] The time integration template stores at most one interval time information.

[0028] The aforementioned wristband-type nasal inhalation drug delivery device also includes a flow monitoring system in the drug compartment. The flow monitoring system is electrically connected to the nebulization system and includes a flow rate sensor, a sensing battery, and a flow information processing module.

[0029] The flow rate sensor is fixed to the top of the inside of the medicine compartment, the sensing battery is fixed to the side wall inside the end compartment, and the flow information processing template is fixed to the other side wall inside the end compartment. One end of the flow rate sensor is electrically connected to the flow information processing template, and the other end of the flow rate sensor is electrically connected to the sensing battery.

[0030] The flow information processing template is electrically connected to the atomization driving template.

[0031] The aforementioned wristband-type nasal inhalation drug delivery device has honeycomb-shaped small holes, with 20 to 40 holes evenly distributed along the central axis of the drug compartment in the horizontal direction.

[0032] The aforementioned wristband-type nasal inhalation drug delivery device includes a drug storage compartment comprising a first compartment, a second compartment, and a partition. Both the first and second compartments are located below the drug inlet. One side of the partition is fixedly connected to the first compartment, and the other side of the partition is fixedly connected to the second compartment.

[0033] The aforementioned wristband-type nasal inhalation drug delivery device also includes a charging port, which is located on the outer surface of the end chamber and is electrically connected to the storage battery and the sensor battery.

[0034] Compared with the prior art, the beneficial effects of this utility model are:

[0035] 1. The convenience of this utility model is outstanding. It adopts a wristband design, with the two ends of the medicine compartment movably connected to the ring strap, making it easy to wear on the wrist. It can be used at any time during daily activities, without being restricted by location or posture, which greatly improves the convenience of drug administration. It allows patients to easily administer nasal medication in various scenarios such as walking, working, and resting; and it adopts a dual medicine compartment design to prevent the use of medicine when it is unavailable.

[0036] 2. This utility model can achieve timed, quantitative, and uniform drug administration. The interval time is input by pressing the interval button and confirmed by pressing the confirmation button. The interval time is stored in the time integration template. Every specified time, the micro vibration motor vibrates to remind the patient to take the medication. When the patient takes the medication, he / she presses the nebulization button, and the nebulizer atomizes the liquid medicine in the drug storage chamber. The atomized liquid medicine passes through the flow sensor and is delivered from the drug delivery port. The flow sensor is linked with the nebulization system. After a certain threshold flow rate is reached, the flow information processing template sends information to the nebulization drive template, the nebulization drive template stops driving, the nebulization stops, and the medication administration is completed.

[0037] 3. This utility model integrates the nebulization system, timing system and flow monitoring system into the end chamber. The integrated design has a prominent synergistic effect. The flow monitoring system is electrically connected to the nebulization system. The flow rate sensor can monitor the drug nebulization flow rate in real time. The flow information processing template processes the data and works in conjunction with the nebulization drive template, which further ensures the accuracy of the drug dosage and makes the treatment process more scientific and reliable.

[0038] 4. This utility model has a sophisticated design and wide applicability. When the drug is a solid rod, it can be placed in the storage chamber. This utility model only requires an end chamber and a storage chamber. The drug can be loaded by the detachable structure between the end chamber and the storage chamber. When the condition occurs, the rotating ring can be rotated to open the cover plate to actively inhale the drug gas. When the drug is a liquid, it can be nebulized and administered through the nebulization system. Attached Figure Description

[0039] Figure 1 This is a top view schematic diagram of a wristband-type nasal inhalation drug delivery device according to this utility model;

[0040] Figure 2 This is a schematic diagram of the atomization system of this utility model;

[0041] Figure 3 This is a schematic diagram of the timing system structure of this utility model;

[0042] Figure 4 This is a schematic diagram of the input button, atomizing button, and charging port on the outer surface of the end chamber of this utility model.

[0043] Figure 5 This is a schematic diagram of the flow detection system of this utility model;

[0044] Figure 6 This is a schematic diagram of the opening and closing mechanism and the medicine storage compartment of this utility model.

[0045] Explanation of reference numerals in the attached figures:

[0046] Detailed Implementation

[0047] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0048] Example 1:

[0049] This embodiment can be applied to stick-type rhinitis medications, such as... Figure 1 The wristband-type nasal inhalation drug delivery device shown includes a wristband 1, a drug chamber 2, a drug delivery port 3, and an opening and closing mechanism 4;

[0050] The two ends of the medicine chamber 2 are movably connected to the two ends of the ring belt 1, and the drug administration port 3 is set on the upper surface of the medicine chamber 2. The medicine chamber 2 is connected to the atmosphere through the drug administration port 3, so that the drug in the medicine chamber 2 can evaporate into the atmosphere.

[0051] The opening and closing mechanism 4 is sleeved with the medicine chamber 2, and the lower surface of the opening and closing mechanism 4 is movably connected with the drug delivery hole 3. The lower surface of the opening and closing mechanism 4 can be made to contact or not contact the drug delivery hole 3 by rotating the opening and closing mechanism 4.

[0052] The medicine compartment 2 includes a medicine storage compartment 21 and an end compartment 22. There are two end compartments 22, and the two end compartments 22 are detachably connected to the two ends of the medicine storage compartment 21. If it is necessary to replace the rod-shaped medicine, it can be replaced directly.

[0053] like Figure 2 As shown, this embodiment can also store liquid medicine, so the device also includes a medicine inlet 5. The medicine inlet 5 is located in the middle of the medicine chamber 2. The medicine inlet 5 includes a medicine inlet hole 51 and a cover 52. The cover 52 is hinged to the medicine inlet hole 51 and can be opened and closed freely.

[0054] And reference Figure 3 In this embodiment, the opening and closing mechanism 4 includes a rotating ring 41 and a cover plate 42. The cover plate 42 is fixedly connected to the rotating ring 41, and the lower surface of the cover plate 42 is in close contact with the drug administration hole 3 to achieve a sealing effect on the drug storage chamber 21. The rotating ring 41 is located at the connection between the drug storage chamber 21 and the end chamber 22, and the rotating ring 41 is sleeved with the drug chamber 2. By rotating the rotating ring 41, the position of the cover plate 42 is controlled, thereby achieving the opening and closing effect of the drug administration hole.

[0055] Example 2

[0056] This embodiment is applicable to liquid medications. As shown in Figures 2-6, based on Embodiment 1, the medication chamber 2 further includes an atomizing system 23. The atomizing system 23 is located at the end of the medication storage chamber 21 and the end chamber 22 away from the administration port 3. The atomizing system 23 includes an atomizing plate 231, a battery 232, an atomizing drive template 233, and an atomizing button 234. The atomizing button 234 is located on the lower side of the outer surface of the end chamber 22 and is connected to the end chamber 22. The other end of the atomizing button 234 is connected to the atomizing drive template 233. Atomization is achieved through... The button controls the atomizing drive template 233, which is located inside the end chamber 22 and to the side of the battery 232. The atomizing drive template 233 is electrically connected to the battery 232, which is also located inside the end chamber 22 and electrically connected to the atomizing plate 231. The atomizing plate 231 is fixedly connected to the inner surface of the drug storage chamber 21 at the end away from the drug delivery port 3. When the atomizing button 234 is turned on, the atomizing drive template 233 drives the atomizing plate 231 to atomize the drug solution.

[0057] like Figure 4 As shown, the medication compartment 2 also includes a timing system 24, which is located inside the end compartment 22 near the nebulization system 23. The timing system 24 includes a time integration template 241, a micro vibration motor 242, and an input button 243. The input button 243 is located to the side of the nebulization button 234 and is electrically connected to the battery 232 and the time integration template 241. The input button controls the interval information required by the patient. After the interval information is input into the time integration template 241, the time template 241 will drive the micro vibration motor to vibrate at specific intervals. The patient wears the device on their hand, which serves as a reminder to take the medication.

[0058] The time-integrated template 241 is located on one side of the atomization drive template 233, and the time-integrated template 241 is electrically connected to the micro vibration motor 242; the micro vibration motor 242 is fixedly connected to the inner surface of the end chamber 22, making the vibration more obvious.

[0059] Specifically, the input button 243 includes a confirm button 2431, a cancel button 2432, and an interval button 2433;

[0060] The interval button 2433 sets the interval information based on the number of presses. Specifically, when the number of presses is n, the interval information is n hours, where n is less than or equal to 12. In this embodiment, pressing the interval button 2433 4 times sets the interval information to vibrate every 4 hours. This interval information is temporarily stored in the time integration template 241. When the time integration template 241 temporarily stores the interval information, the interval information is stored by confirming the button 2431. If the interval button 2433 is accidentally pressed 5 times, the interval information can be deleted by pressing the cancel button 2432, and the interval information can be re-entered by pressing the interval button again. In addition, the cancel button 2432 can also delete the existing interval information. The time integration template 241 stores at most one set of interval information. After confirmation, if the interval button is accidentally pressed again, the interval information will be re-entered.

[0061] like Figure 5 As shown, the medicine chamber 2 also includes a flow monitoring system 25, which is electrically connected to and linked with the atomization system 23. The flow monitoring system 25 includes a flow velocity sensor 251, a sensing battery 252, and a flow information processing template 253. The flow velocity sensor 251 is fixed to the top of the inside of the medicine chamber 2, the sensing battery 252 is fixed to the side wall inside the end chamber 22, and the flow information processing template 253 is fixed to the other side wall inside the end chamber 22. One end of the flow velocity sensor 251 is connected to the flow information processing template 253. The flow information processing template 253 is electrically connected to the flow rate sensor 251, and the other end of the flow rate sensor 251 is electrically connected to the sensing battery 252. The flow information processing template 253 is electrically connected to the atomization drive template 233. When the atomizing plate 231 is working, the flow rate sensor 251 detects the flow rate in the drug storage chamber. The flow information template 252 receives the flow rate information and calculates the actual amount of gas that has been atomized. When the threshold designed at the factory is reached, the information is fed back to the atomization system 23, and the atomization drive template 233 stops driving and terminates the atomization process.

[0062] like Figure 1 As shown, the drug delivery hole 3 is a honeycomb-shaped hole. In this embodiment, the number of drug delivery holes 3 is 38, and the 38 drug delivery holes 3 are evenly distributed in the central part of the horizontal direction of the drug chamber 2.

[0063] In addition, such as Figure 6 As shown, in this embodiment, the medicine storage compartment 21 includes a first compartment 211, a second compartment 212, and a partition 213. The first compartment 211 and the second compartment 212 are both located below the medicine inlet 51. One side of the partition 213 is fixedly connected to the first compartment 211, and the other side of the partition 213 is fixedly connected to the second compartment 212. This can remind the patient to replenish the medicine in a timely manner and also prevent the patient from running out of medicine when the compartment is empty.

[0064] In this embodiment, the device also includes a charging port 6, which is disposed on the outer surface of the end compartment 22. The charging port 6 is electrically connected to the battery 232 and is used to charge the battery 232.

[0065] Usage instructions and working principle:

[0066] I. Instructions for use:

[0067] For stick-type rhinitis medication, the stick-type medication is placed in the medication storage chamber 21, worn on the wrist via the ring strap 1, and the medication administration port 3 is opened by rotating the opening and closing mechanism 4, so that the medication in the medication chamber 2 evaporates into the atmosphere and is inhaled.

[0068] For liquid medication, open the cap 52 and inject the liquid medication into the drug storage chamber 21 through the drug inlet 51, then close the cap 52. Press the nebulization button 234, and the nebulization drive template 233 drives the nebulizer plate 231 to atomize the liquid medication. Rotate the rotating ring 41, causing the cap plate 42 to rotate and disengage from the drug delivery port 3, allowing the patient to inhale through the drug delivery port 3. Before use, a medication interval reminder can be set via the input button 243. The time integration template 241 drives the micro vibration motor 242 to vibrate and remind the patient to take the medication based on the set interval information. The flow rate sensor 251 monitors the flow rate in real time and sends feedback to the nebulization system 23 to stop nebulization when the threshold is reached.

[0069] Working principle:

[0070] The rod-shaped drug relies on natural evaporation and is dispersed into the air through the open administration port 3 for the user to inhale.

[0071] When administering liquid medication, the battery 232 provides power, and the nebulization button 234 controls the nebulization drive template 233 to activate the nebulizer plate 231 to atomize the medication, which is then output from the administration port 3. The timing system 24 input button 243 sets the interval time information, which is stored in the time integration template 241. Pressing the set interval time activates the micro-vibration motor 242 to remind the patient. The flow rate sensor 251 of the flow monitoring system 25 monitors the flow rate. The flow information processing template 253 calculates the flow rate information and compares it with a threshold. If the threshold is reached, feedback is sent to the nebulization drive template 233 to stop the nebulization process.

[0072] It will be apparent to those skilled in the art that this invention is not limited to the details of the exemplary embodiments described above, and that it can be implemented in other specific forms without departing from the spirit or essential characteristics of this invention. Therefore, the embodiments should be considered illustrative and non-limiting in all respects, and the scope of this invention is defined by the appended claims rather than the foregoing description. Thus, all variations falling within the meaning and scope of equivalents of the claims are intended to be included within this invention, and no reference numerals in the claims should be construed as limiting the scope of the claims.

[0073] The above are merely preferred embodiments of this utility model, but the scope of protection of this utility model is not limited thereto. Any equivalent substitutions or modifications made by those skilled in the art within the scope of the technology disclosed in this utility model, based on the technical solution and inventive concept of this utility model, should be included within the scope of protection of this utility model.

Claims

1. A nose ring type inhalation administration device, characterized by comprising: It includes a ring belt (1), a medicine chamber (2), a drug delivery port (3), an opening and closing mechanism (4), and a drug inlet (5); The two ends of the medicine chamber (2) are movably connected to the two ends of the ring belt (1), the drug administration hole (3) is set on the upper surface of the medicine chamber (2), and the medicine chamber (2) is connected to the atmosphere through the drug administration hole (3). The opening and closing mechanism (4) is sleeved with the medicine chamber (2), and the lower surface of the opening and closing mechanism (4) is movably connected to the drug administration hole (3). The medicine compartment (2) includes a medicine storage compartment (21) and an end compartment (22). The number of end compartments (22) is 2, and the two end compartments (22) are detachably connected to the two ends of the medicine storage compartment (21). The inlet (5) is located in the middle of the medicine compartment (2). The inlet (5) includes an inlet hole (51) and a cover (52). The cover (52) is hinged to the inlet hole (51). The opening and closing mechanism (4) includes a rotating ring (41) and a cover plate (42). The cover plate (42) is fixedly connected to the rotating ring (41), and the lower surface of the cover plate (42) is in close contact with the administration hole (3); The rotating ring (41) is located at the connection between the medicine storage chamber (21) and the end chamber (22), and the rotating ring (41) is sleeved with the medicine chamber (2).

2. The loop nose inhaler according to claim 1, wherein The medicine compartment (2) also includes an atomizing system (23), which is located at the end of the medicine storage compartment (21) and the end compartment (22) away from the drug delivery port (3). The atomizing system (23) includes an atomizing plate (231), a battery (232), an atomizing drive template (233), and an atomizing button (234). The atomizing button (234) is located on the lower side of the outer surface of the end chamber (22). The atomizing button (234) is connected to the end chamber (22), and the other end of the atomizing button (234) is connected to the atomizing drive template (233). The atomizing drive template (233) is disposed inside the end chamber (22) and is disposed on the side of the battery (232). The atomizing drive template (233) is electrically connected to the battery (232). The battery (232) is located inside the end compartment (22), and the battery (232) is electrically connected to the atomizing plate (231); The atomizing plate (231) is fixedly connected to the inner surface of the drug storage chamber (21) at the end away from the drug delivery port (3).

3. A looped nasal inhalation administration device according to claim 2, wherein The medicine compartment (2) also includes a timing system (24), which is located inside the end compartment (22) near the atomizing system (23). The timing system (24) includes a time integration template (241), a micro vibration motor (242), and an input button (243). The input button (243) is located to the side of the atomizing button (234), the input button (243) is electrically connected to the battery (232), and the input button (243) is electrically connected to the time integration template (241); The time integration template (241) is disposed on one side of the atomization driving template (233), and the time integration template (241) is electrically connected to the micro vibration motor (242); The micro vibration motor (242) is fixedly connected to the inner surface of the end chamber (22).

4. The loop nose inhaler of claim 3, wherein The input button (243) includes a confirmation button (2431), a cancel button (2432), and an interval button (2433). The interval button (2433) sets the interval information by the number of times it is pressed. The specific setting method is as follows: when the number of presses is n, the interval information is n hours, where n is less than or equal to 12. The interval information is temporarily stored in the time integration template (241). The time integration template (241) temporarily stores the interval information. The interval information can be stored by the confirmation button (2431) or deleted by the cancellation button (2432). The time integration template (241) stores at most one copy of the interval time information.

5. The loop nose inhaler of claim 2, wherein, The medicine compartment (2) also includes a flow monitoring system (25), which is electrically connected to the atomization system (23). The flow monitoring system (25) includes a flow rate sensor (251), a sensing battery (252), and a flow information processing template (253). The flow rate sensor (251) is fixed to the top of the inside of the medicine compartment (2), the sensing battery (252) is fixed to the side wall inside the end compartment (22), the flow information processing template (253) is fixed to the other side wall inside the end compartment (22), one end of the flow rate sensor (251) is electrically connected to the flow information processing template (253), and the other end of the flow rate sensor (251) is electrically connected to the sensing battery (252); The flow information processing template (253) is electrically connected to the atomization driving template (233).

6. A looped nasal inhalation administration device as claimed in claim 1, wherein, The drug delivery hole (3) is a honeycomb-shaped hole, and the number of drug delivery holes (3) is 20 to 40. The 20 to 40 drug delivery holes (3) are evenly distributed in the central part of the horizontal direction of the drug chamber (2).

7. The looped nasal inhalation administration device according to any one of claims 1 to 6, wherein The medicine storage compartment (21) includes a first compartment (211), a second compartment (212), and a partition (213). The first compartment (211) and the second compartment (212) are both located below the medicine inlet (51). One side of the partition (213) is fixedly connected to the first compartment (211), and the other side of the partition (213) is fixedly connected to the second compartment (212).

8. A looped nasal inhalation administration device according to claim 7, wherein The wristband-type nasal inhalation drug delivery device also includes a charging port (6), which is located on the outer surface of the end chamber (22) and is electrically connected to the storage battery (232) and the sensor battery (252).

Images